| Identification | More | [Name]
Ranimustine | [CAS]
58994-96-0 | [Synonyms]
1-(2-chloroethyl)-1-nitroso-3-[[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-methoxy-oxan-2-yl]methyl]urea
RANIMUSTINE
RCL L16,919-6
Cymerin
MCNU
Methyl 6-[[[(2-chloroethyl)nitrosoamino]carbonyl]amino]-6-deoxy-α-D-glucopyranoside
NSC-0270516
Ranomustine
Thymerin
Methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-α-D-glucopyranoside | [Molecular Formula]
C10H18ClN3O7 | [MDL Number]
MFCD00866369 | [Molecular Weight]
327.72 | [MOL File]
58994-96-0.mol |
| Hazard Information | Back Directory | [Description]
Ranimustine, a new nitrosourea derivative, is a water soluble antitumor agent with low
hematological toxicity and diabetogenic effect. It is reportedly effective in the treatment
of hematologic malignancies, especially the myeloproliferative disorders. | [Originator]
Tokyo Tanabe (Japan) | [Uses]
Glucocorticoid with low systemic absorption anti-inflammatory agent | [Definition]
ChEBI: Ranimustine is an organic molecular entity. | [Brand name]
Cymerine |
|
| Company Name: |
LGM Pharma
|
| Tel: |
1-(800)-881-8210 |
| Website: |
www.lgmpharma.com |
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.bocsci.com |
| Company Name: |
Alfa Chemistry
|
| Tel: |
+1 (201) 478-8534 |
| Website: |
www.alfa-chemistry.com |
|